{
    "organizations": [],
    "uuid": "60a4256492421469e980fd4a8e5b1ca2559a701a",
    "author": "",
    "url": "https://www.reuters.com/article/brief-foamix-announces-positive-results/brief-foamix-announces-positive-results-from-late-stage-acne-treatment-study-idUSFWN1OZ0N7",
    "ord_in_thread": 0,
    "title": "BRIEF-Foamix Announces Positive Results From Late Stage Acne Treatment Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 4, 2018 / 5:49 PM / Updated 7 minutes ago BRIEF-Foamix Announces Positive Results From Late Stage Acne Treatment Study Reuters Staff 1 Min Read \nJan 4 (Reuters) - Foamix Pharmaceuticals Ltd: \n* FOAMIX ANNOUNCES POSITIVE RESULTS FROM PHASE 3 OPEN-LABEL SAFETY EXTENSION EVALUATING FMX-101 TOPICAL MINOCYCLINE FOAM FOR TREATMENT UP TO 1 YEAR Source text for Eikon: Further company coverage:",
    "published": "2018-01-04T19:48:00.000+02:00",
    "crawled": "2018-01-04T20:06:17.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "positive",
        "result",
        "late",
        "stage",
        "acne",
        "treatment",
        "study",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "foamix",
        "pharmaceutical",
        "ltd",
        "foamix",
        "announces",
        "positive",
        "result",
        "phase",
        "safety",
        "extension",
        "evaluating",
        "topical",
        "minocycline",
        "foam",
        "treatment",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}